ArticleCureus2024
A Scoping Review of Factor-Related Cognitive Impairment in Interstitial Lung Disease.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Neurocognitive Impairment in Idiopathic Pulmonary Fibrosis: A Systematic Review of Current Evidence.Medical sciences (Basel, Switzerland) · 2025Pooled it
- Cognitive impairment, depression, anxiety, and health-related quality of life in fibrotic ILD: a cross-sectional study.BMC pulmonary medicine · 2026Article
- Neurological Symptom Frequency, Cognitive Dysfunction, and Motor Impairment in Patients with Interstitial Lung Disease: A Cross-Sectional Analysis.Journal of clinical medicine · 2026Article
- Neurocognitive Dysfunction in Fibrosing Interstitial Lung Diseases: A Multidimensional Analysis of Pulmonary, Cognitive, and Clinical Correlates.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the risk factors for cognitive impairment in interstitial lung disease (ILD) can help guide disease management tailored to cognitive function. However, no review articles or randomized controlled trial articles have been found for cognitive impairment in ILD. This scoping review aimed to systematically map studies on factor-related cognitive impairment in ILD and organize current knowledge. Literature on cognitive impairment in ILD was retrieved from PubMed, Scopus, and EBSCO and manually searched using Google. Three researchers screened the relevant literature. Six studies were extracted: four were case-control studies; one was a cross-sectional study; and one was a prospective cohort study. The extracted literature lacked studies with a high level of evidence and only reported factor-related cognitive impairment in ILD, not risk factors. Factors related to cognitive impairment were carbon monoxide pulmonary diffusing capacity, FEV1/FVC, hospitalization for lung transplantation, delirium during hospitalization, apnea-hypopnea index and Epworth sleepiness scale scores, idiopathic pulmonary fibrosis, abnormal pulmonary artery pressure, hypoxemia, post-exercise arterial blood oxygen partial pressure and heart rate, and six-minute walk test results. This scoping review presents the current knowledge on the risk factors for cognitive dysfunction in ILD. The extracted literature did not include reports on the risk factors for cognitive impairment in ILD and was limited to reports on related factors. Building evidence on this topic is desirable for understanding the risk factors for cognitive impairment in patients with ILD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.